ARCHIVES

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 34 | September 14, 2012

Download PDF Visit The Full Archive

Related Articles

AACR, ASCO Members Concerned Over Ethics, Social Issues, And What To Do About Them

May 16, 1975

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

Letter to the Editor: Colleagues describe Bunn As Leader, Patient Advocate

January 12, 1996